PLX

#3115
Protalix BioTherapeutics, Inc. Common Stock
2.8300 USD
+1.07%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
2.7890
2.8450
Jahresspanne
2.5850
3.1900
Tagesänderung
+1.07%
Monatliche Änderung
-3.08%
6 month change
-3.08%
Jahresänderung
-3.08%
Vorheriger Schlusskurs
2.8000
Open
2.8200
Bid
2.8300
Ask
2.8330
Low
2.7890
High
2.8450
Volumen
288
Open full chart

Financials

Overview Finanzbericht Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

Nachrichten